日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multiomics profiling of urothelial carcinoma in situ reveals CIS-specific gene signature and immune characteristics

尿路上皮原位癌的多组学分析揭示了 CIS 特异性基因特征和免疫特征

Meenakshi Anurag, Trine Strandgaard, Sung Han Kim, Yongchao Dou, Eva Comperat, Hikmat Al-Ahmadie, Brant A Inman, Ann Taber, Iver Nordentoft, Jørgen Bjerggaard Jensen, Lars Dyrskjøt, Seth P Lerner

Expression of ADAM Proteases in Bladder Cancer Patients with BCG Failure: A Pilot Study

卡介苗治疗失败的膀胱癌患者中 ADAM 蛋白酶的表达:一项初步研究

Renate Pichler, Andrea Katharina Lindner, Georg Schäfer, Gennadi Tulchiner, Nina Staudacher, Martin Mayr, Eva Comperat, Jacob J Orme, Gert Schachtner, Martin Thurnher

Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models

PI3K/AKT 通路激活诱发肾盂尿路上皮癌:在人类肿瘤中的鉴定和在动物模型中的确认

Chao-Nan Qian, Kyle A Furge, Jared Knol, Dan Huang, Jindong Chen, Karl J Dykema, Eric J Kort, Aaron Massie, Sok Kean Khoo, Kristin Vanden Beldt, James H Resau, John Anema, Richard J Kahnoski, Hans Morreau, Philippe Camparo, Eva Comperat, Mathilde Sibony, Yves Denoux, Vincent Molinie, Annick Vieillef

Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: correlation with clinical parameters and outcome

转移性黑色素瘤患者 VEGFR-3(Flt-4)的肿瘤表达和循环水平:与临床参数和结果的相关性

Roger Mouawad, Jean-Philippe Spano, Eva Comperat, Frederique Capron, David Khayat